Blog - Page 175 of 5624 - QualityStocks

WednesdayOct 01, 2025 9:51 am

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Begins Trading on Tradegate Exchange in Berlin

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced that its shares are now listed on the Tradegate Exchange in Berlin, Germany, one of Europe’s most active investor-focused platforms, marking a key step in expanding its global shareholder base and access to European capital markets as the Company advances from explorer to fully integrated gold producer at its Beacon Gold Mill in the Abitibi Gold Belt; the listing, which does not involve issuance of new shares or dilution, complements its primary CSE listing and provides broader visibility,…

WednesdayOct 01, 2025 9:45 am

SuperCom Ltd. (NASDAQ: SPCB) Expands European Presence with New $7 Million German Contract, Covering Multiple Programs

The electronic monitoring (“EM”) company won Germany’s national EM contract, valued at up to $7 million over four years. SuperCom displaced a provider that had supplied the country’s EM technology for more than 20 years. Germany becomes the ninth nation to adopt SuperCom’s domestic violence solution. Contract covers multiple programs, including GPS tracking, domestic violence monitoring, home detention, and alcohol monitoring. SuperCom (NASDAQ: SPCB), a global provider of secured e-Government, IoT, and cybersecurity solutions, has been awarded a national electronic monitoring (“EM”) contract in Germany, marking a strategic expansion into Europe’s largest economy. The program budget is estimated at $7…

WednesdayOct 01, 2025 9:00 am

Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-powered PredictBBB.ai Platform Helps Hoth Therapeutics Streamline Candidate Selection in Drug Development

Hoth Therapeutics (NASDAQ: HOTH) is using Lantern Pharma’s (NASDAQ: LTRN) PredictBBB.ai(TM) platform to accelerate development timelines, reduce risk, and improve candidate selection. This technology helps determine whether or not a candidate is able to cross the blood-brain barrier or not, which is a major holdup for many drug development companies. Leadership at both Lantern Pharma and Hoth Therapeutics are enthusiastic about the collaboration and how it can help deliver life-changing therapies for patients. Hoth Therapeutics (NASDAQ: HOTH), a biopharmaceutical company, recently announced that the company is using an AI-powered platform developed by Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotech company…

WednesdayOct 01, 2025 9:00 am

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Closes $7.5 Million Public Offering to Extend Cash Runway Through 2026

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on treatments for rare diseases, announced the closing of its $7.5 million public offering of 5,555,560 shares of common stock and accompanying warrants at $1.35 per share, with proceeds intended to fund R&D, commercialization, working capital, and general corporate purposes; the financing, which included participation from existing and institutional healthcare investors, also amends prior warrants to a $1.35 exercise price and extends the company’s cash runway through the end of 2026. To view the full press release, visit https://ibn.fm/SXoge About Soligenix Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing…

WednesdayOct 01, 2025 9:00 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Secures Scilex Investment, IBM Amendment, and Multi-Million-Dollar Commitment to Accelerate Growth

Datavault AI (NASDAQ: DVLT) has rapidly shifted from an overlooked microcap to a standout AI growth story after announcing three major catalysts in September: a $150 million strategic investment from Scilex that reset its balance sheet and plugged the company into biotech data markets, an amended subscription agreement with IBM that eased payment obligations and freed resources for scaling, and a multi-million-dollar commitment from IBM valued at about $5 million in engineering, technical sales, and quantum expertise to accelerate Datavault’s platform development, integrations, and enterprise adoption—support that underscores IBM’s direct alignment with Datavault’s long-term mission. To view the full press…

TuesdaySep 30, 2025 11:15 am

SuperCom Ltd. (NASDAQ: SPCB) Expands U.S. Footprint with New Wisconsin Project, 12th State in One Year

SuperCom has secured a new electronic monitoring project with a sheriff’s department in Wisconsin, marking the company’s 12th new U.S. state entry since August 2024. The company has signed over 30 contracts and 11 reseller partnerships in the U.S. during the same period. The project introduces a domestic violence prevention program and may expand into GPS tracking, as the company deploys its PureSecurity(TM) platform, offering modular GPS, RFID, and mobile solutions tailored to public safety needs. Research indicates electronic monitoring programs can reduce recidivism rates. SuperCom (NASDAQ: SPCB), a global provider of secured e-Government, IoT, and cybersecurity solutions, has expanded…

TuesdaySep 30, 2025 11:14 am

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Prices $344.4 Million in PIPEs to Launch Digital Asset Treasury Strategy

Predictive Oncology (NASDAQ: POAI) announced the pricing of two concurrent private placement transactions totaling approximately $344.4 million to support its new digital asset treasury strategy centered on ATH, the native token of the Aethir ecosystem; the deal includes a $51.7 million cash PIPE and a $292.7 million crypto PIPE involving pre-funded warrants, with proceeds earmarked for ATH acquisition, working capital, and general corporate purposes. To view the full press release, visit https://ibn.fm/lLvrg About Predictive Oncology Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence and machine learning to expedite early drug discovery and enable…

TuesdaySep 30, 2025 10:52 am

QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Unveils 2026 MVR Series With First HVAC-Equipped Electric Carts

Massimo Group (NASDAQ: MAMO) announced the launch of its 2026 MVR Series, introducing the MVR HVAC Golf Cart and MVR Cargo Max Electric Utility Cart—the first fully enclosed electric carts in their class to come standard with integrated heating and air conditioning, delivering up to 45 miles per charge, 25 mph top speed, and year-round comfort for recreational, municipal, and industrial users. To view the full press release, visit https://ibn.fm/QVYpr About Massimo Group Massimo Group is a manufacturer and distributor of powersports products. Headquartered in Texas, the company offers a full lineup of UTVs, ATVs, and minibikes built for outdoor adventure. Massimo…

TuesdaySep 30, 2025 10:30 am

FDA Guidance Sets Lantern Pharma Inc. (NASDAQ: LTRN) On a Path Toward Realizing Its Clinical Trial Plans for Rare Pediatric Cancer Therapy

Texas-based clinical-stage biotechnology company Lantern Pharma Inc. is developing a number of clinical trials, using its proprietary drug candidates and computational biology and machine learning platform, to target conditions with unmet medical needs A recent Type C meeting with the U.S. Food and Drug Administration provided the company with guidance in working through the regulatory pathway and designing the trial for its investigational therapy LP-184/STAR-001, which will seek a means of battling pediatric brain cancers Lantern Pharma is also using drug candidates in trials to combat glioblastoma (“GBM”), triple-negative breast cancer, non-small cell lung cancer in non-smokers, non-Hodgkin’s lymphoma, and…

TuesdaySep 30, 2025 10:30 am

QualityStocksNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Signs LOI to Acquire BioSpark AI Technologies

Fifty 1 Labs (OTC: FITY) announced it has signed a Letter of Intent to acquire BioSpark AI Technologies Inc., a Vancouver-based developer of patented AI systems for clinical data extraction and real-time analysis, in a deal that includes BioSpark’s proprietary LLM ensemble technology, intellectual property, and a contingent payment of 25 million common shares tied to revenue milestones, further advancing Fifty 1 Labs’ strategy to deliver transformative AI-powered healthcare and biotechnology solutions. To view the full press release, visit https://ibn.fm/27fJy About Fifty1 AI Labs Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY), is redefining drug discovery by…

Site Search

Company Search

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Begins Trading on Tradegate Exchange in Berlin

SuperCom Ltd. (NASDAQ: SPCB) Expands European Presence with New $7 Million German Contract, Covering Multiple Programs

Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-powered PredictBBB.ai Platform Helps Hoth Therapeutics Streamline Candidate Selection in Drug Development

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Closes $7.5 Million Public Offering to Extend Cash Runway Through 2026

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Secures Scilex Investment, IBM Amendment, and Multi-Million-Dollar Commitment to Accelerate Growth

SuperCom Ltd. (NASDAQ: SPCB) Expands U.S. Footprint with New Wisconsin Project, 12th State in One Year

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Prices $344.4 Million in PIPEs to Launch Digital Asset Treasury Strategy

QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Unveils 2026 MVR Series With First HVAC-Equipped Electric Carts

FDA Guidance Sets Lantern Pharma Inc. (NASDAQ: LTRN) On a Path Toward Realizing Its Clinical Trial Plans for Rare Pediatric Cancer Therapy

QualityStocksNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Signs LOI to Acquire BioSpark AI Technologies

Market Basics

Newsletter Publishers

Public Companies